In the in vitro experiments above, surface-exposed CD47 on cancer cells binds with a monoclonal antibody (B6H12.2), whereas in the body, CD47 would bind with SIRPα, an immune receptor found on macrophages, dendritic cells, and other cells of the innate immune system [16]. Here, SIRPA is linked to cancer.